Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Alpha Dextrin Market to Reach $102,156.7 thousand, Globally, by 2034 at 3.8% CAGR: Allied Market Research

This image opens in the lightbox

News provided by

Allied Market Research

13 Nov, 2025, 15:01 GMT

Share this article

Share toX

Share this article

Share toX

The growth of the alpha dextrin market is driven by rise in demand for product stabilization and texture enhancement and increase in demand for excipients.

WILMINGTON, Del., Nov. 13, 2025 /PRNewswire/ -- Allied Market Research published a report, titled, "Alpha Dextrin Market By Type (Native Alpha-Dextrin, Modified Alpha-Dextrin), and Application (Food, Pharnaceutical, Industrial, Cosmetics, Animal Nutrition): Global Opportunity Analysis and Industry Forecast, 2024-2034". According to the report, the alpha dextrin market was valued at $68,000.0 thousand in 2023, and is estimated to reach $102,156.7 thousand by 2034, growing at a CAGR of 3.8% from 2024 to 2034.

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A325769

Prime determinants of growth

The alpha dextrin market is driven by factors such as increase in demand for excipients, and product stabilization and texture enhancement. However, high production costs and availability of cheaper alternatives restrict the market growth. Moreover, potential to use as a feedstock for biodegradable plastics offers new opportunities in the coming years.

Report coverage & details:

 

Report Coverage

 

 

Details

 

 

Forecast Period

 

 

2024–2034

 

 

Base Year

 

 

2023

 

 

Market Size in 2023

 

 

$68,000.0 thousand

 

 

Market Size in 2035

 

 

$102,156.7 thousand

 

 

CAGR

 

 

3.8 %

 

 

No. of Pages in Report

 

 

238

 

 

Segments covered

 

 

Type, Application, and Region

 

 

Drivers

 

 

Increasing demand for excipients

 

Green chemistry initiatives

 

Product stabilization and texture enhancement

 

 

Opportunities

 

 

Potential to use as a Feedstock for biodegradable plastics

 

Expansion in natural cosmetics market

 

 

Restraints

 

 

High production costs

 

Availability of cheaper Alternatives

 

Buy This Research Report (238 Pages PDF with Insights, Charts, Tables, and Figures): https://www.alliedmarketresearch.com/alpha-dextrin-market/purchase-options

The modified alpha dextrin segment to maintain its leadership status throughout the forecast period

Based on type, the modified alpha dextrin segment dominated the market in 2023 accounting for more than three-fifths of the market share and is expected to dominate the market during the forecast period owing to its enhanced functional properties, such as improved solubility, stability, and controlled-release capabilities. These attributes make it highly suitable for advanced applications in pharmaceuticals, nutraceuticals, and functional food. Modified alpha-dextrin is preferred for its ability to encapsulate sensitive ingredients, mask unpleasant tastes, and improve bioavailability. Its versatility in formulating specialized products gives it a competitive edge over native forms. The segment is expected to retain its lead during the forecast period with ongoing innovations and rising demand for high-performance ingredients.

The pharmaceutical segment to maintain its lead position during the forecast period

On the basis of application, the pharmaceuticals segment dominated the market in 2023 accounting for less than one-third of the market share and is expected to maintain its dominance during the forecast period. Its ability to enhance the bioavailability of active pharmaceutical ingredients (APIs) and protect them from degradation makes it highly valuable in tablets, capsules, and liquid drug forms. In addition, alpha-dextrin is non-toxic, biocompatible, and exhibits excellent encapsulation properties, which are essential in controlled-release and targeted drug delivery systems. The demand for functional excipients like alpha-dextrin is expected to remain strong as pharmaceutical companies continue to innovate in formulation technologies, securing the dominance of the segment during the forecast period.

Europe to maintain its dominance by 2035

Based on region, North America held the highest market share in terms of revenue in 2023, accounting for less than one-third of the market share and is expected to maintain its dominance during the forecast period. North America is driven by its well-established food and pharmaceutical industries, robust research and development infrastructure, and growing demand for functional food ingredients and excipients. The region's dominance is supported by the presence of key manufacturers, advanced processing technologies, and a strong regulatory framework that promotes innovation while ensuring product safety and quality. In the food industry, alpha dextrin is widely used for its excellent solubility, stability, and emulsifying properties, catering to the increasing consumer preference for health-oriented and clean-label products.

Enquiry Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A325769

Leading Market Players: -

  • Sigma Aldrich
  • Wacker Chemie Ag
  • Glentham Life Sciences
  • Chem-Impex International
  • Fengchen Group Co., Ltd.
  • Aogu Biotech
  • Cavcon
  • Zhishang Chemical
  • Thermo Fisher Scientific Inc.
  • Cayman Chemical Company

The report provides a detailed analysis of these key players in the alpha dextrin market. These players have adopted different strategies such as acquisition, partnerships, and new product launches to increase their market share and maintain dominant shares in the market. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Explore AMR's Extensive ongoing Coverage on Food and Beverages Domain:

Food Texture Market  : Global Opportunity Analysis and Industry Forecast, 2022 - 2032

Dextrin Market  : Global Opportunity Analysis and Industry Forecast, 2021-2030

Functional Carbohydrates Market  : Global Opportunity Analysis and Industry Forecast, 2019-2026

Infant Nutrition Market  : Global Opportunity Analysis and Industry Forecast, 2022 - 2032

Food Preservatives Market  : Global Opportunity Analysis and Industry Forecast, 2022-2031

Biostimulant Market  : Global Opportunity Analysis and Industry Forecast, 2020-2031

Probiotic Drinks Market  : Global Opportunity Analysis and Industry Forecast, 2020-2031

About us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact us:

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg 

Modal title

Also from this source

Fleet card market was valued at $1 trillion in 2024 in the short term and to reach $4.8 trillion by 2034 globally, at 16.5% CAGR: Allied Market Research

Fleet card market was valued at $1 trillion in 2024 in the short term and to reach $4.8 trillion by 2034 globally, at 16.5% CAGR: Allied Market Research

Allied Market Research published a report, titled, "Fleet Card Market By Type (Open Loop, Closed Loop, and Dual Network Cards), Vehicle Type...

Adaptive Cruise Control (ACC) System Market to Reach $12.7 billion, Globally, by 2034 at 8.5% CAGR: Allied Market Research

Adaptive Cruise Control (ACC) System Market to Reach $12.7 billion, Globally, by 2034 at 8.5% CAGR: Allied Market Research

Allied Market Research published a report, titled, "Adaptive Cruise Control (ACC) System Market by Technology (Infrared Sensor, Laser Sensor, Image...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.